About This Webinar
Migraine is a complex, chronic disease that results in significant patient and economic burden. Migraine ranks second worldwide in terms of years lost due to disability. Direct annual all cause health care costs for a migraine patient is over twice that of a non-migraine patient. Indirect costs from the impact of the disease on a patient’s ability to function (absenteeism and presenteeism) total over $35B annually. Therefore, it is important to appropriately manage a person with migraine who experiences greater than 4 attacks a month (or severe disability from at least two attacks a month) and may benefit from preventive therapy.
One of the main goals of preventive therapy is to improve function and reduce disability. Utilizing a stratified care approach to preventive migraine treatment is key to accomplish this goal. The objective for this webinar is to review the migraine disease state, with an emphasis on the impact on patient function and quality of life, and outline the atogepant clinical data for the preventive treatment of migraine.
Attendees Will Learn About
- The stratified care approach to preventive treatment of migraine
- Migraine CGRP Treatment landscape (current and future)
- Atogepant migraine expanded indication
